137 related articles for article (PubMed ID: 9152112)
1. Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
Chamberlain MC
Arch Neurol; 1997 May; 54(5):554-8. PubMed ID: 9152112
[TBL] [Abstract][Full Text] [Related]
2. Chronic oral VP-16 for recurrent medulloblastoma.
Chamberlain MC; Kormanik PA
Pediatr Neurol; 1997 Oct; 17(3):230-4. PubMed ID: 9390699
[TBL] [Abstract][Full Text] [Related]
3. Recurrent cerebellar gliomas: salvage therapy with oral etoposide.
Chamberlain MC
J Child Neurol; 1997 Apr; 12(3):200-4. PubMed ID: 9130095
[TBL] [Abstract][Full Text] [Related]
4. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
Chamberlain MC
Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460
[TBL] [Abstract][Full Text] [Related]
5. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Chamberlain MC
Arch Neurol; 1995 May; 52(5):509-13. PubMed ID: 7733847
[TBL] [Abstract][Full Text] [Related]
6. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Chamberlain MC; Grafe MR
J Clin Oncol; 1995 Aug; 13(8):2072-6. PubMed ID: 7636550
[TBL] [Abstract][Full Text] [Related]
7. Recurrent brainstem gliomas treated with oral VP-16.
Chamberlain MC
J Neurooncol; 1993 Feb; 15(2):133-9. PubMed ID: 8509818
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy for recurrent spinal cord ependymona.
Chamberlain MC
Cancer; 2002 Sep; 95(5):997-1002. PubMed ID: 12209682
[TBL] [Abstract][Full Text] [Related]
9. Response of recurrent medulloblastoma to low-dose oral etoposide.
Ashley DM; Meier L; Kerby T; Zalduondo FM; Friedman HS; Gajjar A; Kun L; Duffner PK; Smith S; Longee D
J Clin Oncol; 1996 Jun; 14(6):1922-7. PubMed ID: 8656261
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN; Smith A; Foreman N; Bouffet E
Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
Needle MN; Molloy PT; Geyer JR; Herman-Liu A; Belasco JB; Goldwein JW; Sutton L; Phillips PC
Med Pediatr Oncol; 1997 Jul; 29(1):28-32. PubMed ID: 9142202
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Fulton D; Urtasun R; Forsyth P
J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
[TBL] [Abstract][Full Text] [Related]
15. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
16. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
18. Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.
Kobrinsky NL; Packer RJ; Boyett JM; Stanley P; Shiminski-Maher T; Allen JC; Garvin JH; Stewart DJ; Finlay JL
J Neurooncol; 1999; 45(1):47-54. PubMed ID: 10728909
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas.
Chamberlain MC; Kormanik P
J Neurooncol; 1999 May; 43(1):71-8. PubMed ID: 10448874
[TBL] [Abstract][Full Text] [Related]
20. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
